{"id":406523,"date":"2025-09-15T00:30:00","date_gmt":"2025-09-14T22:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/abordagens-terapeuticas-baseadas-na-patogenese-e-na-nefroproteccao\/"},"modified":"2025-09-15T14:08:15","modified_gmt":"2025-09-15T12:08:15","slug":"abordagens-terapeuticas-baseadas-na-patogenese-e-na-nefroproteccao","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/abordagens-terapeuticas-baseadas-na-patogenese-e-na-nefroproteccao\/","title":{"rendered":"Abordagens terap\u00eauticas baseadas na patog\u00e9nese e na nefroprotec\u00e7\u00e3o"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>A nefropatia por imunoglobulina (Ig) A \u00e9 considerada uma causa importante de insufici\u00eancia renal terminal. Por conseguinte, na perspetiva atual, a nefropatia por IgA n\u00e3o deve ser classificada como uma doen\u00e7a benigna. Felizmente, o espetro de tratamento expandiu-se nos \u00faltimos anos. Para al\u00e9m da TRF-budesonida oral e do medicamento DEARA sparsentan, que j\u00e1 foram autorizados em muitos pa\u00edses, est\u00e3o atualmente em desenvolvimento numerosas terap\u00eauticas baseadas na patog\u00e9nese. No entanto, as op\u00e7\u00f5es terap\u00eauticas nefroprotectoras cl\u00e1ssicas &#8211; RAAS-i, SGLT-2-i, MRA e GLP-1-RA &#8211; tamb\u00e9m continuam a desempenhar um papel importante    <\/strong>.<\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fabordagens-terapeuticas-baseadas-na-patogenese-e-na-nefroproteccao%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>A nefropatia por imunoglobulina (Ig) A \u00e9 considerada uma causa importante de insufici\u00eancia renal terminal. Por conseguinte, na perspetiva atual, a nefropatia por IgA n\u00e3o deve ser classificada como uma&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fabordagens-terapeuticas-baseadas-na-patogenese-e-na-nefroproteccao%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":126520,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Glomerulonefrite: Nefropatia por IgA  ","footnotes":""},"category":[11551,11521,11453,11407,11305,11426,11529],"tags":[84476,84473,63999,65626,68417,77597,22966,18638,84474,84475],"powerkit_post_featured":[],"class_list":["post-406523","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-estudos","category-farmacologia-e-toxicologia","category-gastroenterologia-e-hepatologia","category-medicina-interna-geral","category-nefrologia-pt-pt","category-relatorios-do-congresso","tag-abordagens-terapeuticas-pt-pt","tag-deara-pt-pt","tag-glomerulonefrite-pt-pt-2","tag-glp-1-ra-pt-pt","tag-mra-pt-pt","tag-nefropatia-por-iga","tag-nefroproteccao","tag-sglt-2-i-pt-pt","tag-sparsentan-pt-pt","tag-trf-budesonida-pt-pt","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-03 07:01:01","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":406441,"slug":"enfoques-terapeuticos-basados-en-la-patogenesis-y-nefroprotectores","post_title":"Enfoques terap\u00e9uticos basados en la patog\u00e9nesis y nefroprotectores","href":"https:\/\/medizinonline.com\/es\/enfoques-terapeuticos-basados-en-la-patogenesis-y-nefroprotectores\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/406523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=406523"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/406523\/revisions"}],"predecessor-version":[{"id":408757,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/406523\/revisions\/408757"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/126520"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=406523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=406523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=406523"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=406523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}